AFP, goat anti-FOXA2, goat anti-HNF4α, rabbit anti-ALB, goat anti-KDR, mouse anti-CD31, mouse anti-CK18, mouse anti-CK19, mouse anti-VIM, or with the following IgG: mouse IgG, goat IgG or rabbit IgG as negative controls. The cells were then incubated with a donkey anti-rabbit IgG-Cy5, donkey anti goat IgG-A488, donkey anti mouse IgG-A488, donkey anti goat IgG-Cy3 or donkey anti mouse IgG-Cy3. Cells were finally counterstained with DAPI. Stained cells were visualized using a confocal or regular fluorescent microscope (Leica) and images captured using the Leica software. The list of antibodies is provided in Table S2 .
Immunocytochemistry on human tissues
Liver tissues were harvested and fixed with 4% paraformaldehyde for subsequent immunostaining. OCT-embedded sections of fixed liver were permeabilized with PBS/Triton 0.3% for 10 minutes at room temperature. The sections were incubated with primary antibodies overnight (rabbit anti-ALB, rabbit anti-CD31 and goat anti-KDR or with the mouse IgG and rabbit IgG as negative controls). The sections were then incubated with a donkey anti-rabbit IgG-Cy5 and donkey anti goat IgG-Cy3. Cells were finally counterstained with DAPI. Stained cells were visualized using a fluorescent confocal microscope (Leica) and images captured using Leica software. The list of antibodies is provided in Table S2 .
PAS staining
Cells were fixed with 4% PFA at room temperature for 10 minutes, incubated with the periodic acid solution (Sigma Aldrich) for 5 minutes at room temperature, and washed with water. Shiff's reagent (Sigma Aldrich) was added for 15 minutes at room temperature. Cells were then washed with water, and photographed with a Leica upright microscope.
Tube formation assay 250 000 cells were plated onto 12-well plates coated with matrigel (BD Biosciences) and cultured in EGM-2 media (Lanza) for 18 hours at 37 o C. Photographs were taken 18 hours later.
Flow cytometry analyses and Immunocytochemistry on mouse tissues
Trunks of E10.5 embryos or E13.5 fetal livers were dissected and dissociated into single cell suspensions for flow cytometry analysis and immunocytostaining. Trunks of E10.5 embryos were individually washed with cold IMDM and trypsinized with 0.25% trypsin for 5 minutes at 37°C to obtain single cell suspensions. E13.5 fetal livers were individually triturated and dissociated at 37°C in 0.2% collagenase (Sigma Aldrich, St Louis, MO) with 20% fetal bovine serum in phosphate buffered saline (PBS) for 8~10 minute. After centrifugation, cells were counted and stained with KDR-PECy7, CD31-PE, EpCAM-APC or DLK-PE antibodies for flow cytometry analysis. The list of antibodies is provided in Table S3 .
Immunohistochemistry of mouse tissues E8.5, 9.5, 10.5 embryos or E13.5 fetal livers were fixed overnight with 4% PFA at 4°C for 2 hours. Adult livers were fixed overnight with 4% PFA at 4°C. Samples were then dehydrated with 30% sucrose and embedded in OCT. Cryosections of 6 to 8-μm were immunostained as indicated with human tissues. The list of antibodies is provided in Table S3 .
Virus generation and infection
To produce HCV for infections, we utilized a chimeric HCV genome, termed Jc1, that encoded the structural proteins and a portion of NS2 from the HC-J6 isolate cloned in the context of the rest of the genome from the JFH-1 isolate due to its ability to produce a high level of infectious virus in cell culture (Pietschmann et al., 2006) . Plasmids encoding the Jc1 genome was provided by Dr Charles Rice (Rockefeller University). HCV stocks were produced as previously described (Ploss et al., 2009) . Briefly, supernatants from Huh-7.5 cells transfected by electroporation with in vitro transcribed HCV genomic RNA were collected at 2, 3, and 4 days post-transfection, filtered (0.45 m pore size). HCV stocks were concentrated 200-times by centrifugation through a 20% sucrose cushion for 2h at 4°C and 34K rpm. Infections were performed, in triplicate, on cells seeded on 48 well plates with 10μL of HCV added in 0.2mL fresh media. Twenty-four hours post infection, cells were washed three times with fresh media to remove virus present in the inoculum. The HCV polymerase inhibitor 2'C-methyl-adenosine (2'CMA) (Carroll et al., 2003) was provided by Timothy Tellinghuisen (Scripps Research Institute) and used at 6 µM to inhibit HCV intracellular RNA replication.
HCV RNA Extraction and qRT-PCR Analysis
Quantification of HCV RNA present in cells or supernatant was performed by quantitative real time reverse transcriptase (RT) PCR analysis. For the intracellular HCV RNA quantification, total RNA was prepared with the RNeasy Micro Kit (Qiagen). For HCV RNA quantification in cell culture supernatant, the media of HCV infected cells was collected at the indicated time points and viral RNAs were extracted with the Qiamp Viral RNA Mini Kit (Qiagen). QRT-PCR was performed on 20 ng of total RNA or 2 μL of extracted RNA from supernatant with the HCV 5'UTR Taqman assay kit (Pa03453408_s1, Applied Biosystems) and the LightCycler 480 Master Hydrolysis Probes kit (Roche) using the LightCycler 480 II Real Time PCR System (Roche).
Virus titration was performed by limiting dilution assay as previously described (Lindenbach, 2008) . Briefly, rows of Huh-7.5 cells seeded in poly-L-lysine coated 96-well plates at 3 x 10 4 cells/well were infected with serial dilutions of virus. Three days post infection, infected cells were fixed and immunostained for NS5A as described in using the clone 9E10 anti-NS5A antibody, provided by Charles Rice (Rockefeller University) and detection was performed with the ImmPRESS peroxidase:anti-mouse conjugated antibody (Vector Laboratories, Burlingame, CA). Wells that expressed at least one NS5A-expressing cell were counted as positive, and the TCID50 was calculated according to the method of Reed and Muench (Reed and Muench, 1938) .
Fusion assay
Day-5 EBs from H9-GFP or H9-DsRed cells were dissociated with Trypsin/EDTA. The resulting cell suspensions were stained with CXCR4-APC (H9-DsRed) or CXCR4-PE, CD117-PECy7 (H9-GFP) in PBS with BSA 0.1% at 4C for 20 minutes. Cells were sorted with the Aria cell sorter (Becton Dickinson). 30% of CXCR4+cKIT+DsRed+ cells were cocultured with 70% of CXCR4+cKIT+GFP+ cells. The day-9 monolayer hepatic cultures were dissociated with trypsin/EDTA. The resulting cell suspensions were stained with KDR-A647 and CD31-FITC in PBS with BSA 0.1% at 4C for 20 minutes. Cells were sorted with the Aria cell sorter (Becton Dickinson). K+C+ cells and K-C-cells were co-cultured (50:50) in hepatic media. The list of antibodies is provided in Figure S14 .
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